--- title: "WISCOM's controlling shareholder plans to transfer shares through an agreement, and trading will be suspended starting July 21" type: "News" locale: "en" url: "https://longbridge.com/en/news/249331710.md" description: "WISCOM announced that its controlling shareholder, Jiangsu WISCOM Group, is planning a share transfer agreement to transfer 16.01% of its shares, which may lead to a change in the company's control. The company's stock will be suspended from trading starting July 21, 2025, with an expected suspension period of no more than 2 trading days" datetime: "2025-07-21T03:55:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/249331710.md) - [en](https://longbridge.com/en/news/249331710.md) - [zh-HK](https://longbridge.com/zh-HK/news/249331710.md) generator: "portal-rs" --- # WISCOM's controlling shareholder plans to transfer shares through an agreement, and trading will be suspended starting July 21 According to the Zhitong Finance APP, WISCOM (002090.SZ) announced that it recently received a notice from its controlling shareholder, Jiangsu WISCOM Group Co., Ltd. (referred to as "WISCOM Group"), informing that it is planning to transfer shares through an agreement. WISCOM Group intends to transfer 16.01% of the company's shares to the counterparty. Upon completion of this share transfer, it may lead to a change in the company's control. The company's stock will be suspended from trading starting from July 21, 2025 (Monday), and the suspension is expected to last no more than 2 trading days ### Related Stocks - [002090.CN](https://longbridge.com/en/quote/002090.CN.md) ## Related News & Research - [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md) - [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md) - [Innventure directors force management, board to forfeit Accelsius earnout shares tied to DarkNX order](https://longbridge.com/en/news/296352522.md) - [Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows](https://longbridge.com/en/news/296603687.md) - [JEOL-backed study identifies rare-earth-free ferromagnets MoMn2B2 and WMn2B2 for potential permanent magnets](https://longbridge.com/en/news/296544825.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**